Conclusion: Among patients with lupus nephritis, GLP-1 receptor agonists may reduce the risk of progression to end-stage renal disease possibly due to benefits in reducing pro-inflammatory mediators
Zhang Z, Jia J, Lai Y, Ma Y, Weng J, Sun L
Increased glycosaminoglycan synthesis : Reviewed in Pickart & Margolina 2018, supporting structural hydration capacity
When blood sugar drops too low, dosage adjustments or medication reassessment may be required (24)
First, I want to note that a sufficient supply of protein and, above all, essential amino acids , which the body cannot produce itself, is critical for good health
Who is an ideal candidate for GLP-1 weight loss therapy in NYC